November 18, 2019 7:03pm

Monday the close was negative with an A/D line of 18/22, 2 flats, 1 reversed merged (HSGX) and 2 acquired;

November has experienced 7 negative and 5 positive closes

Tax season selling seems to be starting early or is it that sentiment is residing in the basement unable to handle the machine algorithms “rules”

It’s not hard to be right so often, it’s about refining expectation, defining insight and trusting your “gut” versus the machines or algorithms

 

Insight is about understanding perception and is putting into context what is relevant to expectation fulfillment …

 

The Dow closed UP +31.33 (+0.11%), the S&P closed up +1.57 points (+0.05%) and the NASDAQ closed UP +9.11 points (+0.11%)

 

The iShares NASDAQ Biotechnology (IBB) and the SPDR S&P ETF (XBI) indicators:

  • Monday the IBB closed down -0.26% while the XBI closed up +0.24%
  • Friday the IBB closed up +1.50% while the XBI closed up +1.34%

 

The advance/decline line scenario of 45 covered companies: 

  • Monday the close was negative with an A/D line of 18/22, 2 flats, 1 reversed merged (HSGX) and 2 acquired;
  • Friday the close was positive with an A/D line of 26/13, 3 flats, 1 reversed merged (HSGX) and 2 acquired;

 

                                                   

Henry’omics:

Indexes posted minimal gains on Monday before closing little changed as investors digested mixed signals around U.S.-China trade talks.

China is troubled by President Trump saying recently the U.S. would not roll back tariffs as they thought both sides had agreed to do so in principle.

The so-called phase one deal was announced last month and is expected to be signed sometime this month. The optimism around that agreement, coupled with easier monetary policy from the Fed, helped spark the stock market’s rally to record highs <CNBC>.

 

CEOs have GOT to start articulating their differentiation, understanding forward leaning statements - to define thier ability to br considered a BUY, not for today or tomorrow but, for months!

MY question - how many are investing in their own stocks???

 

Decliners:

  • Ionis Pharmaceuticals (IONS -$0.893);
  • AxoGen (AXGN -$0.59);
  • BioLife Solutions (BLFS -$0.48);
  • Fate therapeutics (FATE -$0.40);
  • Sage Therapeutics (SAGE -$0.36 after Friday’s +$5.53 after Thursday’s -$3.26);

Incliners:

  • ReNeuron (RENE.L +$11.50);
  • CRISPR Therapeutics (CRSP +$1.66 after Friday’s +$1.81);
  • Global Blood Therapeutics (GBT +$0.74 after Friday’s +$2.41 and Thursday’s -$1.49);
  • Alnylam Pharmaceuticals (ALNY +$0.68 after Friday’s +$1.59);
  • Ultragenyx (RARE +$0.64 after Friday’s -$0.70);

 

The percentage (%) indicators: 

  • Monday’s range of the 18 upside was +0.01% (BLUE) to +11.50% (RENE.L) while the  22 downside ranged from -0.23% (VYGR) to -4.75% (VSTM);
  • Friday’s range of the 26 upside was +0.12% (BOLD) to +13.75% (ONVO) while the  13 downside ranged from -0.48% (SGMO) to -4.45% (VSTM);

 

Upside volume stats:  to compare

  • Monday: 8 out of the 18 upside had higher than the 3 month average volume;
  • Friday: 8 out of the 26 upside had higher than the 3 month average volume;

Downside volume stats:

  • Monday: 5 out of the 22 downside had higher than the 3 month average volume;
  • Friday: 7 out of the 13 downside had higher than the 3 month average volume;

 

2 flat – ATHX and MDXG with 1 reverse merged (HSGX), 2 acquired (AST & OSIR) and Spark Therapeutics’ (ONCE) acquisition by Roche could be soon according to rumors from FTC by year’s end.

 

November’s sessions:

Monday closed NEGATIVE with 22 decliners, 18 advancers, 2 flats and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Friday closed POSITIVE with 13 decliners, 26 advancers, 3 flats and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Thursday closed NEGATIVE with 25 decliners, 17 advancers, 0 flat and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Wednesday closed NEGATIVE with 29 decliners, 12 advancers, 1 flat and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Tuesday closed NEGATIVE with 29 decliners, 12 advancers, 1 flat and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Monday closed NEGAIVE with 27 decliners, 14 advancers, 1 flat and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Friday closed POSITIVE with 11 decliners, 29 advancers, 2 flats and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Thursday closed POSITIVE with 18 decliners, 21 advancers, 3 flats and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Wednesday closed NEGATIVE with 27 decliners, 13 advancers, 2 flats and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Tuesday closed POSITIVE with 17 decliners, 23 advancers, 2 flats and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Monday closed NEGATIVE with19 decliners, 22 advancers, 1 flat and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Friday closed POSITIVE with 7 decliners, 33 advancers, 2 flats and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.